Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Onmiddellijke effecten van PETTLEP-gebaseerde AOMI op bovenste ledematen kinematica bij overlevenden van een beroerte

5 november 2026 bijgewerkt door: Abdelrahman Sabee, Istinye University

Directe effecten van PETTLEP-gebaseerde AOMI op bovenste ledematen kinematica bij beroerte-overlevenden: Een gerandomiseerde gecontroleerde studie.

This study investigates the immediate effects of a single session of Physical, Environment, Task, Timing, Learning, Emotion, Perspective (PETTLEP)-based Action Observation and Motor Imagery (AOMI) on upper-limb movement quality in chronic stroke survivors. Stroke frequently causes reduced movement smoothness and prompts compensatory strategies such as trunk displacement and shoulder elevation. Participants received a single session of either PETTLEP-based AOMI (watching mirror-reversed self-observation and performing real-time kinesthetic imagery of a functional Reach-Drink-Return task) or a duration- and structure-matched active sham (non-motor nature videos and resonant breathing). A single smartphone camera and MediaPipe Pose Landmarker were utilized to evaluate immediate changes in movement smoothness (NVP and SPARC), path straightness, shoulder elevation, trunk displacement, movement time, and functional performance (WMFT-4).

Studie Overzicht

Gedetailleerde beschrijving

This study employs a single-blind, pretest-posttest, prospective randomized controlled trial design to evaluate the acute effects of a single session of Physical, Environment, Task, Timing, Learning, Emotion, Perspective (PETTLEP)-based Action Observation and Motor Imagery (AOMI) in stroke patients. Following a stroke, patients often develop pathological movement patterns and maladaptive compensatory strategies, such as trunk displacement or shoulder girdle elevation, due to impaired motor commands. Traditional task practice requires voluntary motor output that many severely impaired patients lack. Motor imagery combined with action observation offers a cognitive simulation alternative that activates neural motor planning circuits.A total of 28 eligible stroke survivors will be randomized in a 1:1 ratio into an experimental (AOMI) group or a control group. Baseline kinematics of a standardized Reach-to-Drink task will be recorded using MediaPipe, a markerless motion capture system utilizing smartphone cameras.The intervention lasts approximately 13 minutes in total. The experimental group will engage in a scaffolded AOMI protocol. This includes action observation (watching a 1st-person video of the task) and selective motor imagery with specific constraints targeting movement smoothness and the inhibition of compensatory trunk and shoulder movements. The control group will perform matched-duration non-motor mental tasks, focusing on forming mental images that contain no movement, such as calm natural scenes, colors, or light. They will be explicitly instructed to avoid imagining any upper-extremity movements. Immediately following the intervention, the reach-to-drink task will be re-assessed using the MediaPipe system to quantify short-term changes in movement smoothness (Number of Velocity Peaks and Spectral Arc Length - SPARC), trunk displacement, and shoulder girdle elevation.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

24

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Istanbul, Turkije (Türkiye)
        • Neurorehabilitation Clinic, Istinye University Liv Bahçeşehir Hospital
      • Istanbul, Turkije (Türkiye)
        • Physical Medicine and Rehabilitation Outpatient Clinic, Biruni University Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

40 jaar tot 80 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Female and male adults aged 40 to 80 years with a diagnosis of unilateral ischemic or hemorrhagic stroke.
  • A first-ever unilateral ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), or recurrent stroke that left no residual motor deficit from the earlier strokes.
  • Mild to moderate spasticity (Modified Ashworth Scale ≤ 2).
  • Medically stable patients, with no active or uncontrolled systemic illness.
  • Ability to sit unsupported for at least 30 minutes and be able to perform brief cognitive-motor exercises.
  • Able to perform the brief cognitive-motor exercises included in the protocol.
  • Medical Research Council (MRC) muscle strength grade of 3 or higher.

Exclusion Criteria:

  • Other central nervous system disorders (e.g., Parkinson's disease, multiple sclerosis, traumatic brain injury).
  • Musculoskeletal or orthopedic conditions causing restriction of movement in the upper-limb (such as fixed contractures, severe joint deformities, shoulder subluxation).
  • Moderate or severe sensory loss (NIHSS sensory score ≥ 2), or moderate or severe neglect (NIHSS extinction/inattention score ≥ 2).
  • Uncontrolled seizures, severe cardiovascular instability, or any other contraindication to imagery.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Experimental Group: PETTLEP-based AOMI

Participants will receive a single 13-minute session of a scaffolded AOMI protocol. The session includes a preparation phase involving sensory transfer using the unaffected arm, action observation of a 1st-person video, and selective motor imagery with smoothness and trunk control constraints. No physical execution of the task is performed during the intervention.

A mental practice protocol involving sensory preparation (using the unaffected arm to transfer sensation), action observation, and motor imagery of a reach-to-drink task with selective functional constraints targeting movement smoothness, trunk stability, and shoulder control.

Sham-vergelijker: Control Group: Cognitive and Somatic Control

A duration-matched 13-minute session comprising non-motor nature footage (beach, forest, waterfall) paired with scene imagery, followed by paced resonant slow breathing (6 breaths/min) using an expanding/contracting visual circle, containing no upper-limb motor content.

Structured non-motor mental tasks, including attention to breathing and calm mental imagery (e.g., natural scenes or colors), timed to match the experimental intervention and explicitly designed to engage attention without any motor system participation.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Movement Smoothness (Number of Velocity Peaks)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Movement smoothness of the affected upper extremity will be quantified as the total Number of Velocity Peaks (NVP) by MediaPipe. Lower NVP values indicate a more continuous movement.

Immediately before and after the 13-minute intervention session.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Movement Smoothness (Spectral Arc Length - SPARC)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

A secondary measure of smoothness calculated using Spectral Arc Length (SPARC) across different phases of the task by MediaPipe. Higher SPARC values indicate smoother movement.

Immediately before and after the 13-minute intervention session.
Path Straightness
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Evaluated as a ratio (0-1) during the reach and reach-to-drink phases. It is calculated by dividing the straight-line distance between the start and end of the wrist path by the total path length travelled. Values closer to 1.0 indicate a straighter, more efficient goal-directed movement path.

Immediately before and after the 13-minute intervention session.
Trunk Displacement (Compensatory Strategy)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Measured in centimeters (cm) as the maximum anterior horizontal shift of the midpoint between the shoulders in the direction of hand travel from lift onset to the highest wrist point, converted using a participant-specific body-based scale factor. Larger values indicate greater compensatory trunk movement.

Immediately before and after the 13-minute intervention session.
Shoulder Girdle Elevation (Compensatory Strategy)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Measured in centimeters (cm) as the maximum upward vertical displacement of the affected shoulder in the image plane after lift onset (following median smoothing over a 9-frame window). Larger values reflect greater compensatory shoulder hitching during upper-limb movement.

Immediately before and after the 13-minute intervention session.
Upper-Extremity Function (Wolf Motor Function Test, Short Form - WMFT-4)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Upper-extremity functional performance will be assessed using the four-item short form of the Wolf Motor Function Test (WMFT-4). Completion time and functional performance scores will be recorded for each item.

Immediately before and after the 13-minute intervention session.
Movement Imagery Ability (Kinesthetic and Visual Imagery Questionnaire-10 - KVIQ-10)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Evaluates visual and kinesthetic movement-imagery capacity. The visual and kinesthetic subscale scores are summed separately; each ranges from 5 to 25, and the total score ranges from 10 to 50. Higher scores signify greater vividness of imagery.

Immediately before and after the 13-minute intervention session.
Pain - Visual Analog Scale (VAS)
Tijdsspanne: Immediately before and immediately after the 25-minute intervention session.

Participants indicate their pain intensity by placing a mark on a 10-cm horizontal line. The left side is labeled "no pain" (0) and the right side is labeled "worst pain imaginable".

Immediately before and immediately after the 25-minute intervention session.
Visual Analog Mood Scale - 4 dimensions (VAMS-4)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

Evaluates immediate changes in mood state across four dimensions (happy, sad, calm, and tense). Participants rate how they feel at the moment on a 0-10 scale (0 = not at all, 10 = extremely) to control for non-specific emotional responses to the intervention.

Immediately before and after the 13-minute intervention session.
Motor Difference Rating Scale (MDRS)
Tijdsspanne: Immediately before and after the 13-minute intervention session.

A two-item 0-10 self-report scale assessing perceived motor control. Before the intervention, participants rate how well they can control the muscles of the affected arm (0 = no control, 10 = full normal control); immediately after, they rate how much difference they feel in muscle control resulting from the session.

Immediately before and after the 13-minute intervention session.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie directeur: Begüm Kara Kaya, Asst. Prof, Istinye University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

10 april 2026

Primaire voltooiing (Werkelijk)

5 oktober 2026

Studie voltooiing (Werkelijk)

5 oktober 2026

Studieregistratiedata

Eerst ingediend

27 maart 2026

Eerst ingediend dat voldeed aan de QC-criteria

27 maart 2026

Eerst geplaatst (Werkelijk)

2 april 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

9 november 2026

Laatste update ingediend die voldeed aan QC-criteria

5 november 2026

Laatst geverifieerd

1 oktober 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data (IPD) will not be shared to ensure the strict privacy and confidentiality of the stroke survivors participating in this study. The data collected involves specific clinical and kinematic assessments conducted for an academic Master's thesis. The informed consent obtained from participants covers the use of their data for this specific research project and allows for publication in aggregate form only. It does not explicitly grant permission for open public data sharing. Therefore, only summary and aggregate data will be reported in the final thesis and any resulting peer-reviewed publications.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren